Canada's Biomanufacturing Advantage - Turning Innovation into Global Partnerships
Day 1 Global Pharma Outlook Stage
06/10/2026 14:15 - 14:40pm
Contributors
Andy Sheldon : CEO - Biologics Manufacturing Centre (BMC)
Canada is emerging as a destination of choice for life sciences investment, offering world-class talent, a trusted regulatory environment, and a collaborative innovation ecosystem. This presentation will explore how the Biologics Manufacturing Centre (BMC), a strategic Canadian biomanufacturing asset, turns innovation into commercial opportunity by enabling technology transfer, manufacturing readiness, and international partnerships. By connecting innovators, industry, and government, BMC provides a platform for companies seeking to expand in North America, reduce investment risk, strengthen supply chain resilience, and accelerate the path from development to production.